Amgen's market cap is currently $146.96B. The company's EPS TTM is $6.02; its P/E ratio is 22.33; and it has a dividend yield of 3.44%. Amgen is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $5.04. See an overview of income statement, balance sheet, and cash flow financials.
